GL1X · GenesisL1 explorer

MolNFT v1 · #73348 · protein

Structural analysis of pneumocystis carinii and human DHFR complexes with NADPH and a series of five potent 5-(omega-CARBOXY(ALKYLOXY) PYRIDO[2,3-D]PYRIMIDINE derivatives

3NZA · Dihydrofolate reductase: “Structural analysis of pneumocystis carinii and human DHFR complexes with NADPH and a series of five potent…”. X-ray diffraction, 3 ligands (NDP, D2K, CL), 1 pocket (best druggability 0.73). MolNFT v1…

PDB
3NZA
Type
protein
Length
206 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
P16184
Ligands
NDP, D2K, CL
Pockets
1 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 27% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
XDihydrofolate reductase (EC 1.5.1.3)protein20627% helix, 30% strandP16184

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · chains X
  • D2K · ethyl 4-{3-[(2,4-diamino-5-methylpyrido[2,3-d]pyrimidin-6-yl)methyl]-4-methoxyphenoxy}butanoate · ligand · chains X
  • CL · Chloride ion · ion · chains X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14700.730.8242NDP, D2K, CL

Compared structures

  • 3NZA · Structural Analysis of Pneumocystis carinii and Human DHFR Complexes with NADPH and a… · the same entry in another collection · chain X against X, TM-score 1.00
  • P16184 · AlphaFold monomer V2.0 prediction for dihydrofolate reductase (P16184) · a predicted model of the same protein · chain X against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.